万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://care.diabetesjournals.org/
3、投稿网址：https://mc.manuscriptcentral.com/diabetescare
4、官网邮箱：diabetescare@diabetes.org（编辑部）
5、官网电话：(317) 354-1508转1782（编辑部）
6、期刊刊期：月刊，一个月出版一期。
2021年4月30星期五
投稿须知
【官网信息】
FORMS AND REQUIREMENTS
Manuscript Submission Form
Manuscript submission form addresses ADA's policies on 1) originality and authorship, 2) copyright assignment, and 3) potential conflict of interest, and outlines the Association’s permission policies related to reuse and postprints. ADA will also accept ICMJE's Uniform Disclosure Form for Potential Conflicts of Interest. The corresponding author may complete the electronic submission form on behalf of all authors and upload it with their article files during submission or send it by email attachment to the Editorial Office (editorialoffice@diabetes.org).
Statement of Originality and Authorship. Diabetes Care subscribes to the requirements stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals that authorship implies substantial contributions to conception and design or analysis and interpretation of data and drafting of the article or critical revision for important intellectual content. The editor reserves the right to query authorship contribution.
Any requested changes to authorship (addition or removal of an author) after the initial submission of a manuscript should be requested via email to the Editorial Office (please cc all coauthors on the email). The new author list must be provided, along with a justification for the change. The author(s) being added or removed should send separate correspondence consenting to the change.
Copyright Assignment. The American Diabetes Association holds the copyright on all material appearing in Diabetes Care, unless the content is produced by an employee of the US government as part of the authors' official duties. The corresponding author must check the appropriate box on the manuscript submission form, which transfers copyright to the ADA in accordance with the Copyright Revision Act of 1976.
Conflict of Interest. Please read the ADA Policy Statement on Duality of Interest and check the box for Potential Conflict of Interest Disclosure on the manuscript submission form.
In addition to completing the manuscript submission form, all submitted papers must include a conflict-of-interest statement for all authors in the acknowledgments section. If authors have no relevant conflict of interest to disclose, this should be indicated in the acknowledgments section. Relevant conflict of interest (or lack thereof) should also be disclosed in the authors' comments to the editor during the submission process.
Authorship
Author Contributions. Authors are required to include a paragraph in the Acknowledgments section listing each author's contribution.
Example: “C.K. researched data. L.R. wrote the manuscript and researched data. H.N. reviewed/edited the manuscript. V.S. contributed to the discussion and reviewed/edited the manuscript. N.B. researched data and contributed to discussion. V.G. wrote the manuscript.”
Writing Groups. The names of members of writing groups should be listed at the end of the Acknowledgments section (if no more than two or three short paragraphs); otherwise, please upload these in a separate supplemental material online-only file.
Affiliations. Institutional and/or employment affiliations of all authors should be listed on the title page of the manuscript. In addition, when citing "editorial assistance" or help provided by a colleague, authors are required to list the employer/institution with which that colleague is affiliated.
Example: “The authors acknowledge the editorial assistance of Mark Smith, Global Informatics, Inc.”
Example:“The authors thank Mark Smith, Global Informatics, Inc., for help with preparing the manuscript.”
Reuse
Authors are permitted to reuse portions of their ADA-copyrighted work in their own work, including tables and figures, and to reuse portions or all of their ADA-copyrighted work for lecture or classroom purposes, provided that the proper citation and copyright information is given.
Postprints
Authors are permitted to submit the accepted version of their manuscript to their funding body or institution for inclusion in that funding body or institution's database, archive, or repository, or to post the accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance, provided that the following two conditions are observed:
First, postprints must include the following statement of provenance and, once the final version has been published in the journal, a link to the final published version of the paper on the journal's website:
This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes Care in print and online at http://care.diabetesjournals.org.
Second, the version of the manuscript deposited or posted must be identical to the final accepted version, with the exception of the addition of the above statement and any changes necessary to correct errors. Authors may make changes to the posted version to correct mistakes or may issue an erratum at any time. However, the final published version of the manuscript may not be deposited, posted, or later substituted for the postprint.
MANUSCRIPT CATEGORIES
See Manuscript Format and Style, for detailed instructions on formatting documents.
Original Articles
Original Articles should be arranged in the following order: title page, structured abstract, introduction (no heading), Research Design and Methods, Results, Conclusions, Acknowledgments, References, tables, and figure legends.
A structured abstract is required for all Original Articles. Abstracts for an Original Article should not exceed 250 words. (This is not to be confused with abstracts submitted to the Annual Scientific Meeting, for which the word limit is higher.) The abstract must be self-contained and clear without reference to the text and should be written for a general journal readership. The abstract format should include four sections: Objective (the purpose or hypothesis of study), Research Design and Methods (the basic design, setting, number of participants and selection criteria, treatment or intervention, and methods of assessment), Results (significant data found), and Conclusions (the validity, limitations, and clinical applicability of the study and its results).
The article Research Design and Methods section contains the study design, definitions of terms used in describing the research, population or samples used for the study, measurements obtained and methods used for making them, statistical analysis plan, and any features of the methods used that are specific to this particular research. It should be as concise as possible but provide sufficient detail that a reader can understand all critical aspects of the study without consulting prior publications or supplementary material.
The article Results section describes the main objective data and the results of the statistical analyses performed using them should be included as results. Neither further information on the methods used nor interpretation of the implications of findings should appear among the results—these belong in the Methods and Conclusions sections, respectively.
The article Conclusions section should briefly summarize the study’s main findings and place them in context of past research related to the topic of the article. In particular, it describes how the present observations add new information. Possible clinical relevance of the findings can be discussed but should avoid claims of superiority beyond the study’s context, particularly when modest but statistically significant differences are found that are of uncertain clinical significance. It is desirable to identify both the strengths and limitations of the study and its findings.
The word count limit for Original Articles is 4,000 words, excluding words in tables, table legends, figure legends, title page, acknowledgments, and references.
The article should contain no more than 40 references and the reference section should be single spaced with justified margins.
The article should contain no more than a combination of 4 tables and/or figures.
A conflict-of-interest statement for all authors must be included in the Acknowledgments section of the main document, which should follow the main text and precede the references. If there are no relevant conflicts of interest to disclose, authors should indicate as such in the Acknowledgments section.
In the case of multicenter studies, authors should provide a list of participating investigators in an appendix to the paper. Papers will not be reviewed if this information is not included.
Where appropriate, clinical and epidemiological studies should be analyzed to see if there is an effect of sex or ethnicity. If there is no effect, it should be stated as such in the Results section.
Randomized Clinical Trial Reporting. Authors of reports on randomized controlled trials are required to use the instructions and checklist in the Consolidated Standards of Reporting Trials (CONSORT) Statement. The instructions and checklist are designed to ensure that information pertinent to the trial is included in the study report. CONSORT information may be included in a supplemental material online-only file so that it does not affect word count limitations.
All clinical trials submitted to Diabetes Care for consideration of publication must be registered with a clinical trial registry approved by the International Committee of Medical Journal Editors (ICMJE). Please see Clinical Trials for more information.
Novel Communications in Diabetes
Novel Communications in Diabetes are designed to provide new and exciting findings in clinical research or clinical care in one or more of the following areas:
the feasibility of a "proof of concept" principle or idea
a novel or innovative finding considered as a pilot study when planning for a larger trial
results from early phase human investigation from a small number of subjects including “first in human” studies
new technical advances (i.e., early research on artificial pancreas, glucose monitoring) or advances in diagnostic testing
studies defining a novel molecular target
studies that challenge current thinking for clinical management or novel approach to behavioral management
case report/case studies that represent a unique or novel finding on disease presentation or treatment effects
Novel Communications are not intended to be short reports on studies that are not powered for larger trials or to simply confirm findings from other studies.
A structured abstract of no more than 150 words is required. The abstract must be self-contained and concise, without reference citations, and written for a general journal readership. The abstract should be followed by a short introduction (2–3 sentences) and four concise sections: Research Design and Methods, Results, Conclusions, and References. References are limited to no more than 15. In addition, Novel Communications may contain only one table or one figure.
The format of the title page, margins, text, table, figure, and font size for Novel Communications is the same as for Original Articles. Manuscripts should be double spaced, written in Arial or Times New Roman 12-point font, and saved as a .doc, .txt, or .rtf file. See "Main Document" and "Text composition."
The word count limit for Novel Communications is 1,350 words, including the 150 word abstract. Tables, figures, legends, the title page, acknowledgments, and references are not included in the word count.
Author contributions, statement of guarantor, and conflict-of-interest disclosures for all authors must be included in the Acknowledgments. If authors have no relevant conflict of interest to disclose, it should be indicated as such.
Epidemiological integrity. Diabetes Care receives a large number of submissions with an epidemiological foundation. These largely, but not exclusively, come from hospital clinics, with data derived from electronic medical records or long-established population-based studies. The populations available for these studies may not truly represent the city/area from where they are derived or national demographics. The socio-economic status of the population, different models of health care (for example state funded or private), and ethnicity are some of the factors that need to be taken into consideration. Submissions from existing records or databases should discuss whether the findings and conclusions are applicable only to that population or can be extrapolated to a more general population, perhaps on a national basis. Authors prospectively planning studies, who would like the results to be relevant outside of their clinic, for example, should take care to include a proportion of subjects who are representative of the ethnicity, socio-economic demographic, and health care systems in that area or nation.
Letters
All letters are published online only. Letters are listed in the table of contents of the print version and are assigned an E-page number. Each letter is assigned a unique DOI; when citing a letter, include the DOI (e.g., 10.2337/dcXX-XXXX).
Letters do not have abstracts and should not exceed 500 words for comments and responses or 750 words for Observations(excluding a maximum of 5 references). As with all submissions, letters should be double-spaced and include a title page.
Diabetes Care accepts three types of letters:
Comment Letters comment on a recently published article and should include the cited paper as reference 1 in the reference list. It should be submitted within 3 months of the article's issue publication. Comment letters do not have tables or figures.
Response Letters are an invited letter from the cited author that replies to the comment letter and should include the comment letter as reference 1 in the reference list. Response letters do not have tables or figures.
Observation Letters comment on a relevant finding related to clinical care or research or present a case report/case study. Observation letters are allowed either one table or one figure.
All letters require a signed manuscript submission form from the author(s). A conflict-of-interest statement for all authors must be included in the acknowledgments section of the main document. If there are no relevant conflicts of interest to disclose, authors should indicate as such in the acknowledgments section.
All letters are freely accessible to readers upon publishing.
Commentaries
Commentaries normally accompany an original article and are invited by the editors. Instructions will be provided at the time of solicitation.
Clinical Images in Diabetes
Clinical Images in Diabetes are intended to provide modern views on the pathogenesis of diabetes or its complications, with the aim of linking the clinical course of diabetes and related pathologies with their underlying physiological mechanisms. By presenting highly novel clinical summaries regarding one to no more than three patient descriptions per article, Clinical Images in Diabetes serves as a valuable educational tool to better understand the pathophysiology of diabetes, enhance disease diagnosis, and offer guidance for optimized clinical treatments.
Importantly, although often presented within the context of a case(s), the Clinical Images in Diabetes section is not intended as a primary vehicle for traditional brief/case reports where novel insights and the use of cutting edge diagnostic/treatment tools are lacking. All submissions must include original images or videos as well as useful insight. Images may include, but are not limited to, histopathological specimens, MRI or CT scans, or other radiological imaging techniques.
All submissions will be subjected to rigorous peer review, with novelty and reader interest a high priority for editorial decisions. All submissions will also be evaluated based on how the contribution adheres to the intent of Clinical Images in Diabetes by judging how it advances understanding of underlying pathophysiological mechanisms.
Submissions should include 1–2 figures or videos. All figures must meet the quality standards outlined in Figures. Video submissions are encouraged and may be submitted in any of the standard formats (e.g., .avi, .mov, etc.). Please submit a separate still image for each video file. More information on video submissions can be found in Video. Figures, videos, and still images should be uploaded as separate files.
Note: Any information that might identify a patient or hospital, including a date, should be removed from the image or video. Written permission from the patient, or parent or guardian of a minor child, is required for publication of recognizable images in all forms and media.
The written portion of the submission should include the following:
A standard title page with no more than four authors
A bulleted summary of 5–10 points (200 words or fewer) summarizing the main narrative and including information such as diagnosis, patient characteristics, biological markers, etc.
A main narrative of 800 words or fewer
A standard acknowledgments section
A reference list with 10 or fewer citations
A legend for each figure and video
All authors should consent to the standard ADA copyright and authorship form (manuscript submission form). Standard page charges and fees for color figures will be applied.
Review Articles and Meta-analyses
Please read the criteria and formatting guidelines for meta-analyses and systematic review articles. A meta-analysis may be submitted to the journal without prior approval from the editors. Please query the journal's interest and provide a proposal (as detailed below) if you wish to submit an uninvited review article.
The proposal should include the following:
Why this is an important topic to review, why it is best suited for Diabetes Care, and why the review would appeal to the readership
The article's focus
Major issue(s) to be addressed
Source of original literature to be summarized (including from X year to Y year inclusive)
Method used
All author bios including the background of the author(s) and a description of expertise in the area to be discussed in the review. It is anticipated that the author(s) will have worked and published in the area covered by the review.
Lastly, the authors must disclose whether they propose to write the entire article themselves, whether they received any form of sponsorship or honorarium for the material, and whether a pharmaceutical company or its representative, was involved in the funding or authorship. In addition, the authors must point out any potential conflict of interest with a company whose products will be discussed in the review.
All proposals should be emailed (as Word document attachments) to Shannon Potts (spotts@diabetes.org) in the Editorial Office. Review Articles submitted without prior approval or invitation will be returned. All Review Articles (whether invited or by query) are subject to peer review.
Once approved, guidelines will be sent to the authors.
……
